MIRA INFORM REPORT

 

 

Report Date :           

24.03.2012

 

IDENTIFICATION DETAILS

 

Name :

SOGEVAL

 

 

Registered Office :

200, Avenue De Mayenne, Zi Des Touches, Rue Berthelot, Laval, 53000

 

 

Country :

France

 

 

Financials (as on) :

31.12.2010

 

 

Date of Incorporation :

15.01.1972

 

 

Com. Reg. No.:

712005107

 

 

Legal Form :

Private Subsidiary

 

 

Line of Business :

Production of medicinally active substances to be used for their pharmacological properties in the manufacture of medicaments

 

 

No. of Employees :

207

 

RATING & COMMENTS

 

MIRA’s Rating :

Ba

 

RATING

STATUS

PROPOSED CREDIT LINE

41-55

Ba

Overall operation is considered normal. Capable to meet normal commitments.

Satisfactory

 

Status :

Satisfactory

 

 

Payment Behaviour :

No Complaints

 

 

Litigation :

Clear

 

 

NOTES:

Any query related to this report can be made on e-mail : infodept@mirainform.com while quoting report number, name and date.

 

 

ECGC Country Risk Classification List – September 30th, 2011

 

Country Name

Previous Rating

                   (30.06.2011)                  

Current Rating

(30.09.2011)

France

a2

a2

 

Risk Category

ECGC Classification

Insignificant

 

A1

Low

 

A2

Moderate

 

B1

High

 

B2

Very High

 

C1

Restricted

 

C2

Off-credit

 

D

 


Company name & address 

 

Sogeval

200, Avenue De Mayenne

Zi Des Touches, Rue Berthelot

Laval, 53000

France

Tel:       +33 02 43 49 51 51

Fax:      +33 02 43 53 97 00

Web:     www.sogeval.com

 

 

synthesis  

 

Employees:                  207

Company Type:            Private Subsidiary

Corporate Family:          56 Companies

Ultimate Parent:             SOFIPROTEOL

Incorporation Date:         15-Jan-1972      

Financials in:                 USD (Millions)

Fiscal Year End:                        31-Dec-2010

Reporting Currency:       Euro

Annual Sales:               68.6

Total Assets:                 51.7

 

 

Business Description     

 

Sogeval is primarily engaged in production of medicinally active substances to be used for their pharmacological properties in the manufacture of medicaments; and processing of blood. This class also includes: manufacture of chemically pure sugars; and processing of glands and manufacture of extracts of glands, etc.

 

Industry             

Industry            Biotechnology and Drugs

ANZSIC 2006:    1841 - Human Pharmaceutical and Medicinal Product Manufacturing

NACE 2002:      2441 - Manufacture of basic pharmaceutical products

NAICS 2002:     32541 - Pharmaceutical and Medicine Manufacturing

UK SIC 2003:    2441 - Manufacture of basic pharmaceutical products

US SIC 1987:    2834 - Pharmaceutical Preparations

 

           


Key Executives   

 

Name

Title

Jose Daoudal

President

Herve Bourge

Director

Alain Facelina

EDP manager

Pierre Beauclair

Directeur

Jean-Pascal Barrier

Commercial director

 

Registered No.(FRA): 712005107

 

1 - Profit & Loss Item Exchange Rate: USD 1 = EUR 0.7550783

2 - Balance Sheet Item Exchange Rate: USD 1 = EUR 0.7454064

 

 

Corporate Overview

 

Location

200, Avenue De Mayenne

Zi Des Touches, Rue Berthelot

Laval, 53000

France

Tel:       +33 02 43 49 51 51

Fax:      +33 02 43 53 97 00

Web:    www.sogeval.com

           

Sales EUR(mil):             51.8

Assets EUR(mil):           38.5

Employees:                   207

Fiscal Year End:            31-Dec-2010

Industry:                        Biotechnology and Drugs

Incorporation Date:         15-Jan-1972

Company Type:             Private Subsidiary

Quoted Status:              Not Quoted

Registered No.(FRA):     712005107

President:                     Jose Daoudal

 

Contents

Industry Codes

Business Description

Financial Data

Subsidiaries

Key Corporate Relationships

 


Industry Codes

 

ANZSIC 2006 Codes:

1841     -          Human Pharmaceutical and Medicinal Product Manufacturing

 

NACE 2002 Codes:

2441     -          Manufacture of basic pharmaceutical products

 

NAICS 2002 Codes:

32541   -          Pharmaceutical and Medicine Manufacturing

 

US SIC 1987:

2834     -          Pharmaceutical Preparations

 

UK SIC 2003:

2441     -          Manufacture of basic pharmaceutical products

 

Business Description

Sogeval is primarily engaged in production of medicinally active substances to be used for their pharmacological properties in the manufacture of medicaments; and processing of blood. This class also includes: manufacture of chemically pure sugars; and processing of glands and manufacture of extracts of glands, etc.

 

More Business Descriptions

Pharmaceutical and Medicine Manufacturing

 

 

Financial Data

Financials in:

EUR(mil)

 

Revenue:

51.8

Assets:

38.5

Current Assets:

25.8

 

Total Liabilities:

38.5

 

Issued Capital:

10.0

 

Net Worth:

18.1

 

 

 

Date of Financial Data:

31-Dec-2010

 

1 Year Growth

11.0%

NA

Subsidiaries

Company

Percentage Owned

Country

Sogeval Laboratories, Inc.

 

United States of America

 

 

 

 

Key Corporate Relationships

Bank:

Bnp Paribas

 

 

 

 

 

 

 

 

 

 


 

Corporate Family

Corporate Structure News:

 

S O F I P R O T E O L
Sogeval

Sogeval 
Total Corporate Family Members: 56 

 

 

 

 

Company Name

Company Type

Location

Country

Industry

Sales
(USD mil)

Employees

S O F I P R O T E O L

Parent

Paris

France

Miscellaneous Financial Services

3.4

39

Soprol Societe Participation Oleagineu

Subsidiary

Paris

France

Miscellaneous Financial Services

0.1

2,100

Soc Agro Industrielle De Patrimoine

Subsidiary

Paris

France

Biotechnology and Drugs

2,215.3

749

Lesieur

Subsidiary

Asnieres Sur Seine

France

Food Processing

920.7

611

Lesieur Generale Condimentaire

Subsidiary

Asnieres Sur Seine

France

Food Processing

97.5

106

Expur SA

Subsidiary

Bucharest

Romania

Food Processing

 

572

Lmt Oleagineux

Subsidiary

Paris

France

Food Processing

24.1

74

Diester Industrie

Subsidiary

Paris

France

Chemical Manufacturing

2,479.0

60

Diester Industrie International Ou En Abrege Dii

Subsidiary

Paris

France

Chemical Manufacturing

260.0

150

Novaol SRL

Subsidiary

Milano

Italy

Oil and Gas Operations

498.4

57

Novance SAS

Subsidiary

Compiegne

France

Biotechnology and Drugs

67.7

125

Hoso

Subsidiary

Paris

France

Food Processing

263.6

 

Diol Production

Subsidiary

Venette

France

Personal and Household Products

15.0

 

Diester Industrie Atlantique

Subsidiary

Paris

France

Retail (Specialty)

9.6

 

Oleon SA/NV

Subsidiary

Ertvelde

Belgium

Personal and Household Products

512.1

380

Farmor

Subsidiary

St Agathon

France

Food Processing

46.5

178

Eggteam

Subsidiary

Neuvy En Sullias

France

Fish and Livestock

96.8

149

Societe Le Plenier Boscher

Subsidiary

Mur De Bretagne

France

Food Processing

75.0

149

Les Volailles De Keranna

Subsidiary

Guiscriff

France

Food Processing

 

600

Oleon GmbH

Subsidiary

Emmerich Am Rhein, Nordrhein-Westfalen

Germany

Chemical Manufacturing

23.6

108

Sopral

Subsidiary

Bruz

France

Food Processing

30.8

84

Cybelia

Subsidiary

St Gerand

France

Computer Services

13.2

84

Michel Robichon Sas

Subsidiary

Pontivy

France

Food Processing

32.4

74

Soc Interolea Assist & Develop

Subsidiary

Paris

France

Computer Services

22.2

74

France Ponte

Subsidiary

St Germain Les Arpajon

France

Food Processing

 

74

Porcgros

Subsidiary

Rungis

France

Food Processing

35.2

34

France Genes

Subsidiary

Neulliac

France

Fish and Livestock

14.6

34

Agro Evolution

Subsidiary

St Symphorien

France

Biotechnology and Drugs

2.8

14

Terrial

Subsidiary

Bruz

France

Chemical Manufacturing

10.4

7

Val Produits

Subsidiary

Branges

France

Fish and Livestock

2.7

4

Ovoteam

Subsidiary

Naizin

France

Food Processing

114.3

 

Etablissements Le Cam

Subsidiary

Naizin

France

Food Processing

57.9

113

Epi Bretagne Oeufs Sas

Subsidiary

Plaintel

France

Food Processing

35.1

100

3 Vallees

Subsidiary

Ambrieres Les Vallees

France

Food Processing

40.6

74

Domaine Des Acacias

Subsidiary

Sougy

France

Fish and Livestock

2.9

 

Glon Sanders

Subsidiary

St Gerand

France

Miscellaneous Financial Services

0.4

 

Sanders Bretagne

Subsidiary

St Gerand

France

Food Processing

555.8

285

Trade Alliance

Subsidiary

Servon Sur Vilaine

France

Crops

10.7

1

Sanders Participations

Subsidiary

St Gerand

France

Food Processing

0.3

 

Etablissement Abera

Subsidiary

St Brice En Cogles

France

Food Processing

200.1

345

Sogeval

Subsidiary

Laval

France

Biotechnology and Drugs

68.6

207

Sanders Grand Est

Subsidiary

Einville Au Jard

France

Food Processing

68.4

149

Sanders

Subsidiary

Aze

France

Food Processing

67.3

34

Bailet (Maison)

Subsidiary

Nice

France

Food Processing

6.6

14

Sanders Distribution

Subsidiary

Bruz

France

Crops

31.0

13

Sunfeed

Subsidiary

St Gerand

France

Crops

15.4

1

Sanders Aliments

Subsidiary

St Gerand

France

Food Processing

0.1

 

Sanders Ouest

Subsidiary

Etrelles

France

Food Processing

250.0

374

Sanders Nord

Subsidiary

St Nicolas

France

Food Processing

96.5

149

Sanders Centre Auvergne

Subsidiary

Aigueperse

France

Food Processing

61.2

149

Agri Volcans

Subsidiary

Tauves

France

Crops

8.8

14

Sanders Aurore

Subsidiary

Champforgeuil

France

Food Processing

62.5

74

Sanders Adour

Subsidiary

Lons

France

Food Processing

75.4

34

Sanders Perigord

Subsidiary

Boulazac

France

Food Processing

32.6

34

Sanders Thouars

Subsidiary

Thouars

France

Business Services

0.2

 

Soc Progal S A

Subsidiary

Neuvy En Sullias

France

Food Processing

 

 

 

 

 

Executive report

 

Board of Directors

 

Name

Title

Function

 

Jose Daoudal

 

President

Chairman

 

 

Executives

 

Name

Title

Function

 

Jose Daoudal

 

President

President

 

Herve Bourge

 

Director

Administration Executive

 

Chantal Pancaldi

 

Director

Administration Executive

 

Stephen Payan

 

General manager

Administration Executive

 

Alain Facelina

 

EDP manager

Information Executive

 

Jean-Pascal Barrier

 

Commercial director

Commercial Executive

 

Pierre Beauclair

 

Directeur

Manufacturing Executive

 

Pierre Bertoux

 

Directeur

Manufacturing Executive

 

François Biet

 

Directeur

Manufacturing Executive

 

Lionel Jacquot

 

Directeur

Manufacturing Executive

 

 

 

Annual Profit & Loss

 

 

 

 

31-Dec-2010

31-Dec-2009

31-Dec-2008

Period Length

12 Months

12 Months

12 Months

Filed Currency

EUR

EUR

EUR

Exchange Rate (Period Average)

0.755078

0.719047

0.683679

Consolidated

No

No

No

 

 

 

 

Total income

71.5

66.7

63.9

Net sales

68.6

65.0

64.0

Change in stock

-

0.2

-

Unfinished work in progress

1.4

0.9

-

Own work capitalised

-

0.4

0.1

Subsidies for operating costs

0.0

0.0

0.0

Supplementary operating income

1.4

0.3

0.2

Other operating income

0.1

0.1

0.3

Other external charges

17.9

15.7

16.2

Cost of goods sold

31.0

26.3

26.8

Taxes and social security costs

3.1

2.6

2.3

Social charges

4.6

4.5

4.1

Total payroll costs

10.7

10.2

9.4

Cost of stock depreciation and amortisation

0.4

0.6

0.6

Fixed asset depreciation and amortisation

1.5

1.4

1.2

Other operating costs

0.1

0.1

0.2

Total operating costs

67.0

61.5

60.7

Net operating income

4.5

5.2

3.2

Joint venture results

-

-

0.0

Total financial income

2.6

0.3

0.4

Interest payable on loans

6.2

1.2

1.1

Other expenses

0.2

0.6

0.4

Total expenses

6.4

1.8

1.5

Profit before tax

0.7

3.7

2.1

Extraordinary income

0.5

6.4

1.0

Extraordinary expenses

1.0

7.2

1.2

Profit distributed to employees

-

0.5

0.4

Net profit

1.1

2.5

2.1

 


 

Annual Balance Sheet

Financials in: USD (mil)

 

                                                                               

 

 

31-Dec-2010

31-Dec-2009

31-Dec-2008

Filed Currency

EUR

EUR

EUR

Exchange Rate

0.745406

0.696986

0.719399

Consolidated

No

No

No

 

 

 

 

Issued capital

13.4

14.3

2.2

Share premium account

-

-

0.8

Legal reserves

4.6

4.4

3.6

Total reserves

5.1

4.2

3.9

Profits for the year

1.1

2.5

2.0

Profit brought forward from previous year(s)

-

-

1.8

Total stockholders equity

24.3

25.4

14.2

Provisions and allowances

0.7

0.8

0.2

Trade creditors

10.8

8.4

10.0

Bank loans and overdrafts

5.1

1.8

2.6

Other loans

0.1

0.2

0.2

Other liabilities

5.6

22.6

6.4

Debts on fixed assets

0.2

1.4

1.8

Income stated in advance

0.4

0.0

0.8

Taxation and social security

4.4

5.9

3.6

Total current liabilities

23.4

39.5

23.5

Total debts

26.6

40.4

25.4

Regularisation account

0.1

0.0

0.0

Total liabilities (including net worth)

51.7

66.6

39.9

Patents

0.5

0.8

0.8

Goodwill

0.3

0.3

0.3

Other intangibles

0.1

0.1

0.1

Land

0.3

0.3

0.3

Buildings

3.7

3.5

3.7

Other fixed assets

10.1

11.0

8.1

Long-term investments

0.0

0.0

0.0

Other financial assets

2.0

0.0

0.0

Total non-current assets

17.0

16.0

13.2

Prepayments

-

0.0

-

Net stocks and work in progress

13.8

11.2

10.1

Trade debtors

15.7

20.2

12.1

Discounted bills not yet due

0.8

1.2

1.2

Other receivables

4.0

10.8

4.0

Prepaid expenses

0.6

0.2

0.2

Cash and liquid assets

0.4

8.1

0.2

Total current assets

34.6

50.4

26.6

Prepaid expenses and deferred costs

0.2

0.2

0.1

Total assets

51.7

66.6

39.9

 

spacebar

 

Annual Ratios

Financials in: USD (mil)

 

                                                                               

 

 

31-Dec-2010

31-Dec-2009

31-Dec-2008

Period Length

12 Months

12 Months

12 Months

Filed Currency

EUR

EUR

EUR

Exchange Rate

0.745406

0.696986

0.719399

Consolidated

No

No

No

 

 

 

 

Current ratio

1.50

1.30

1.10

Quick ratio

0.90

1.00

0.70

Total liabilities to net worth

1.15%

1.68%

1.96%

Net worth to total assets

0.45%

0.36%

0.33%

Collection period

72.20

96.90

65.90

Stock turnover rate

5.00

6.00

6.00

Asset turnover

1.35%

1.01%

1.53%

Profit margin

0.01%

0.06%

0.03%

Return on assets

0.01%

0.06%

0.05%

Shareholders' return

0.03%

0.16%

0.16%

Sales per employee

1,642.19

1,665.05

1,559.51

Profit per employee

17.12

95.23

52.20

Average wage per employee

255.28

260.34

228.68

Net worth

24.3

25.4

14.2

Number of employees

207

184

184

 

 

FOREIGN EXCHANGE RATES

 

Currency

Unit

Indian Rupees

US Dollar

1

Rs.50.91

UK Pound

1

Rs.80.77

Euro

1

Rs.67.40

 

 

RATING EXPLANATIONS

 

RATING

STATUS

 

 

PROPOSED CREDIT LINE

>86

Aaa

Possesses an extremely sound financial base with the strongest capability for timely payment of interest and principal sums

 

Unlimited

71-85

Aa

Possesses adequate working capital. No caution needed for credit transaction. It has above average (strong) capability for payment of interest and principal sums

 

Large

56-70

A

Financial & operational base are regarded healthy. General unfavourable factors will not cause fatal effect. Satisfactory capability for payment of interest and principal sums

 

Fairly Large

41-55

Ba

Overall operation is considered normal. Capable to meet normal commitments.

 

Satisfactory

26-40

B

Capability to overcome financial difficulties seems comparatively below average.

 

Small

11-25

Ca

Adverse factors are apparent. Repayment of interest and principal sums in default or expected to be in default upon maturity

 

Limited with full security

<10

C

Absolute credit risk exists. Caution needed to be exercised

 

 

Credit not recommended

----

NB

New Business

----

 

This score serves as a reference to assess SC’s credit risk and to set the amount of credit to be extended. It is calculated from a composite of weighted scores obtained from each of the major sections of this report. The assessed factors and their relative weights (as indicated through %) are as follows:

 

Financial condition (40%)            Ownership background (20%)                 Payment record (10%)

Credit history (10%)                    Market trend (10%)                                Operational size (10%)

 

 

 

PRIVATE & CONFIDENTIAL : This information is provided to you at your request, you having employed MIPL for such purpose. You will use the information as aid only in determining the propriety of giving credit and generally as an aid to your business and for no other purpose. You will hold the information in strict confidence, and shall not reveal it or make it known to the subject persons, firms or corporations or to any other. MIPL does not warrant the correctness of the information as you hold it free of any liability whatsoever. You will be liable to and indemnify MIPL for any loss, damage or expense, occasioned by your breach or non observance of any one, or more of these conditions

This report is issued at your request without any risk and responsibility on the part of MIRA INFORM PRIVATE LIMITED (MIPL) or its officials.